Castlight Health, inc. (CSLT) Receives Coverage Optimism Score of 0.22
News stories about Castlight Health, inc. (NYSE:CSLT) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Castlight Health, inc. earned a daily sentiment score of 0.22 on Accern’s scale. Accern also assigned media headlines about the software maker an impact score of 88 out of 100, meaning that recent press coverage is very likely to have an effect on the company’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:
- Castlight Health, inc. (NYSE:CSLT) Expected to Announce Quarterly Sales of $30.96 Million (americanbankingnews.com)
- Brokerages Expect Castlight Health, inc. (CSLT) to Post -$0.15 Earnings Per Share (americanbankingnews.com)
- Castlight Health to Announce Second Quarter 2017 Results (finance.yahoo.com)
- Castlight Health, inc. (CSLT) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com)
Castlight Health, inc. (NYSE:CSLT) opened at 4.55 on Monday. The stock’s market cap is $593.84 million. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50. The firm’s 50-day moving average price is $3.88 and its 200-day moving average price is $3.83.
Castlight Health, inc. (NYSE:CSLT) last released its earnings results on Wednesday, April 26th. The software maker reported ($0.05) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.05). Castlight Health, inc. had a negative return on equity of 43.23% and a negative net margin of 48.72%. The firm had revenue of $27.70 million during the quarter, compared to analysts’ expectations of $28.40 million. During the same quarter last year, the business posted ($0.13) earnings per share. The firm’s revenue was up 22.0% on a year-over-year basis. On average, equities analysts predict that Castlight Health, inc. will post ($0.26) EPS for the current fiscal year.
Several brokerages recently weighed in on CSLT. Zacks Investment Research lowered Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Thursday, April 27th. Morgan Stanley lowered Castlight Health, inc. from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $4.00 to $3.75 in a report on Friday, May 12th. ValuEngine lowered Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Friday, May 19th. Chardan Capital began coverage on Castlight Health, inc. in a report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price objective for the company. Finally, BidaskClub raised Castlight Health, inc. from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. Castlight Health, inc. has a consensus rating of “Hold” and a consensus price target of $4.44.
WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/castlight-health-inc-cslt-receives-coverage-optimism-score-of-0-22/1444811.html.
In related news, CAO Priya Jain sold 7,858 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.65, for a total transaction of $28,681.70. Following the completion of the sale, the chief accounting officer now directly owns 20,000 shares of the company’s stock, valued at approximately $73,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Giovanni M. Colella sold 11,456 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.75, for a total value of $42,960.00. Following the sale, the insider now directly owns 88,094 shares of the company’s stock, valued at $330,352.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,051 shares of company stock valued at $140,343. 24.38% of the stock is owned by corporate insiders.
Castlight Health, inc. Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.